astressin and barbituric-acid

astressin has been researched along with barbituric-acid* in 1 studies

Other Studies

1 other study(ies) available for astressin and barbituric-acid

ArticleYear
[The extended amygdala system and self-stimulation of the lateral hypothalamus in rats: modulation with opiates and opioids].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2011, Volume: 97, Issue:2

    Wistar male rats were implanted with bipolar electrodes in the lateral hypothalamus to study self-stimulation reaction in the Skinner box. Simultaneously, the microcanules were implanted into the central nucleus of the amygdala to inject the drugs studied (1 microl in volume for each injection). The blockade of CRF receptors (astressin 1 microg) or sodium influx ionic currents (xycaine, or lidocain 1 microg) by means of intrastructural administration of drugs into the amygdala descreased self-stimulation reaction of the lateral hypothalamus in rats by 29-55%. The inhibition of D2 and D2 dopamine receptors in the amygdala with SCH23390 (1 microg) or sulpiride (1 microg), respectively. reduced self-stimulation too, but in less degree. On the background of blockade of CRF (astressin) and dopamine (sulpiride) receptors, as well as sodium influx ionic currents (lidocain) in the amygdala neurons, psychomotor stimulant amphetamine (1 mg/kg) and barbiturate sodium ethaminal (5 mg/kg) supported their psychoactivating effect on self-stimulation (+30-37%), but fentanyl (0.1 mg/kg) had got no effect. Fentanyl activated self-stimulation moderately only after blockade D1 dopamine receptors with SCH23390. After blockade of CRF receptors, leu-enkephaline strengthened its depressant effect on self-stimulation reaction (-89%). Therefore, if the modulating influence of the amygdala on the hypothalamus is diminished, the reinforcing effects of opiated (fentanyl) and opioids (leuencephaline) will block, but there will be no effect for psychomotor stimulant amphetamine and barbiturate sodium ethaminal.

    Topics: Amphetamine; Amygdala; Analgesics, Opioid; Anesthetics, Local; Animals; Barbiturates; Benzazepines; Corticotropin-Releasing Hormone; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enkephalin, Leucine; Fentanyl; Hypnotics and Sedatives; Hypothalamus; Lidocaine; Male; Neuroprotective Agents; Neurotransmitter Agents; Pentobarbital; Peptide Fragments; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Self Stimulation; Sulpiride

2011